The cost-effectiveness of insulin glulisine in type 2 diabetes in Poland

被引：1
|
作者：
Walczak, J. [1 ]
Dardzinski, W. [1 ]
Kusy, M. [1 ]
Lis, J. [2 ]
Nogas, G. [1 ]
机构：
[1] Arcana Inst, Krakow, Poland
[2] Sanofi Aventis Sp ZOO, Warsaw, Poland
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70715-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A226 / A226
页数：1
相关论文
共 50 条
  • [1] THE COST-EFFECTIVENESS ANALYSIS OF VIDALGLIPTIN IN TYPE 2 DIABETES IN POLAND
    Walczak, J.
    Nogas, G.
    Gebus, E.
    Pawlik, D.
    Pacocha, K.
    VALUE IN HEALTH, 2009, 12 (07) : A406 - A406
  • [2] COST-EFFECTIVENESS OF INSULIN DETEMIR IN PEOPLE WITH TYPE 2 DIABETES IN ROMANIA
    Ionescu-Targoviste, C.
    Wrona, W.
    Schubert, A.
    Niewada, M.
    Czech, M.
    VALUE IN HEALTH, 2012, 15 (07) : A500 - A500
  • [3] THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND
    Kolasa, K.
    Niewada, M.
    de Troconiz, J. Puelles Fernandez
    Townsend, R.
    McEwan, P.
    VALUE IN HEALTH, 2010, 13 (07) : A290 - A290
  • [4] Cost-effectiveness of treatment of type 2 diabetes
    Eastman, RC
    DIABETES CARE, 1998, 21 (03) : 464 - 465
  • [5] The cost-effectiveness of screening for type 2 diabetes
    Engelgau, MM
    Narayan, KMV
    Thompson, TJ
    Boyle, JP
    Williamson, DF
    Manninen, DL
    Dong, FB
    Orians, CE
    Dasbach, EJ
    Teutsch, SM
    Eastman, R
    Herman, WH
    Songer, TJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (20): : 1757 - 1763
  • [6] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
    Marc Evans
    Barrie Chubb
    Jens Gundgaard
    Diabetes Therapy, 2017, 8 : 275 - 291
  • [7] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
    Evans, Marc
    Chubb, Barrie
    Gundgaard, Jens
    DIABETES THERAPY, 2017, 8 (02) : 275 - 291
  • [8] Systematic review of the cost-effectiveness of biphasic insulin aspart 30 in type 2 diabetes
    Valentine, William J.
    Pollock, Richard F.
    Plun-Favreau, Juliette
    White, Jeremy
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (06) : 1399 - 1412
  • [9] Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands
    Roze, S.
    Duteil, E.
    Smith-Palmer, J.
    de Portu, S.
    Valentine, W.
    de Brouwer, B. F. E.
    Reznik, Y.
    de Valk, H. W.
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (08) : 742 - 749
  • [10] COST-EFFECTIVENESS OF DAPAGLIFLOZIN AS ADD-ON TO INSULIN FOR THE TREATMENT OF TYPE 2 DIABETES IN THE NETHERLANDS
    van Haalen, H. G. M.
    Pompen, M.
    Bergenheim, K.
    McEwan, P.
    Townsend, R.
    Roudaut, M.
    VALUE IN HEALTH, 2013, 16 (07) : A441 - A441
12345